These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9340266)

  • 21. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
    Zimlichman R
    Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of losartan on haematology and haemorheology in elderly patients with essential hypertension: a pilot study.
    Shand BI; Gilchrist NL; Nicholls MG; Bailey RR
    J Hum Hypertens; 1995 Apr; 9(4):233-5. PubMed ID: 7595904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan: a new antihypertensive drug.
    Dubois M; Wilson TW
    Can Nurse; 1997 Jun; 93(6):31-4. PubMed ID: 9233121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin receptor antagonists.
    Goldsmith DJ
    Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin II receptors and potassium channels: targets for new cardiovascular drugs.
    Barber DA; Barber CH; Bivins CL; Tackett RL
    J Pract Nurs; 1995 Mar; 45(1):32-9; quiz 40-2. PubMed ID: 7714840
    [No Abstract]   [Full Text] [Related]  

  • 26. [Angiotensin II antagonists: a distinct therapeutic class].
    Waeber B; Brunner HR
    Presse Med; 1996 Oct; 25(32):1533-5. PubMed ID: 8952659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct selective blockade of the vascular angiotensin II receptors in therapy for hypertension and severe congestive heart failure.
    Awan NA; Mason DT
    Am Heart J; 1996 Jan; 131(1):177-85. PubMed ID: 8554006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin II antagonist for heart insufficiency].
    Z Kardiol; 1997 Jun; 86(6 Suppl):1-8. PubMed ID: 9259867
    [No Abstract]   [Full Text] [Related]  

  • 31. Losartan: the first angiotensin receptor antagonist in clinical use.
    Beevers DG
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
    [No Abstract]   [Full Text] [Related]  

  • 32. Losartan in heart failure: preclinical experiences and initial clinical outcomes.
    Sweet CS; Rucinska EJ
    Eur Heart J; 1994 Dec; 15 Suppl D():139-44. PubMed ID: 7713103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin receptors: physiology and pharmacology.
    Guthrie GP
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 29-34. PubMed ID: 7634561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Losartan: An Orally Active Angiotensin II Antagonist. Proceedings of a meeting. Saint Paul de Vence, France, 26-27 June 1992.
    J Hypertens Suppl; 1993 Apr; 11(3):S1-73. PubMed ID: 8315511
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin receptor blockers in essential hypertension.
    Brown MJ
    Lancet; 1993 Dec; 342(8884):1374-5. PubMed ID: 7901674
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension?
    Beevers DG; Lip GY
    J Hum Hypertens; 1997 Jun; 11(6):329-30. PubMed ID: 9249225
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required?
    Morrell NW
    Chest; 1997 May; 111(5):1469-70. PubMed ID: 9149625
    [No Abstract]   [Full Text] [Related]  

  • 38. Failure of losartan to control blood pressure in scleroderma renal crisis.
    Caskey FJ; Thacker EJ; Johnston PA; Barnes JN
    Lancet; 1997 Mar; 349(9052):620. PubMed ID: 9057740
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of angiotensin-II-antagonists in hypertension].
    Birkenhäger WH; de Leeuw PW
    Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1397-402. PubMed ID: 10923148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis.
    Yayama K; Kawao M; Tujii H; Itoh N; Okamoto H
    Eur J Pharmacol; 1993 May; 236(2):337-8. PubMed ID: 8319760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.